Lupus patients get custom steroid tapers in new study
NCT ID NCT03187743
First seen Mar 11, 2026 · Last updated May 24, 2026 · Updated 9 times
Summary
This study looked at a personalized way to reduce steroid doses in people with lupus. 72 patients were followed for 3 months to see how their bodies processed the drug and how their disease activity changed. The goal was to find a safer, more effective tapering plan.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Necker Enfants Malades
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.